INTS: Bathi resik saben saham (EPS TTM) Intensity Tx

Intensity Therapeutics, Inc. (INTS) - logo korporat

The TTM net income per share distribution for Intensity Therapeutics (INTS) visualizes a monetization strategy centered on intratumoral drugs against metastases. The current value is -4.36, highlighting a reliance on venture capital infusions in the absence of stable cash flow. A team of leading oncologists, attracted by the innovative treatment approach, is spearheading the development. This indicator smooths the time lags between corporate news and the market price.

INTS Bathi resik saben saham sajrone 12 wulan pungkasan Intensity Therapeutics (21.02.2024 - 12.11.2026)

Ringkesan rincian data analitis Intensity Therapeutics Inc (INTS)

- rega saham lan prakiraan rega para ahli:
Barang unggulan Intensity Tx

This indicator is calculated by dividing total annual net income by the total number of shares outstanding. The metric reflects the actual efficiency of profit generation per share, neutralizing the impact of issuance. For Intensity Therapeutics (INTS), this calculation highlights the capital's dependence on the success of a single oncology drug. Binary clinical trial risks make profit dynamics extremely volatile. By analyzing this 12-month net income per share chart, an investor assesses the degree of business scalability.

Pesaing utama

IBRX: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku IMCR (immunocore.com)|JANX: Bathi resik saben saham (EPS TTM)|RCUS - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Zymeworks Corp|Bathi resik saben saham sajrone 12 wulan pungkasan Tango Therapeutics Corp (TNGX)|Bathi saben saham sajrone rolas wulan pungkasan Iovance Biotherapeutics (IOVA)|Bathi resik saben saham sajrone 12 wulan pungkasan immatics.com IMTX|Xencor - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben saham (EPS TTM) Compass Therapeutics Inc CMPX|REPL - Bathi saben saham sajrone rolas wulan pungkasan|LYEL (Lyell Pharma) - Bathi saben saham sajrone 12 wulan pungkasan|Innate Pharma S.A. (IPHA) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Pyxis Oncology (PYXS)|Bathi resik saben saham sajrone 12 wulan pungkasan CGEN|IOBT - Bathi resik saben saham sajroning taun lumaku|Bathi resik saben saham sajrone 12 wulan pungkasan STRO (Sutro Bio)|Bathi saben saham sajrone patang kuartal pungkasan INKT|Bathi resik saben saham (EPS TTM) HOWL (Werewolf Therapeutics, Inc.)|Bathi saben saham sajroning taun lumaku IMMX|ALX Oncology Holdings - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan cuebiopharma.com|pdsbiotech.com (PDSB) - Bathi saben saham sajrone rolas wulan pungkasan|Sonnet BioTherapeutics Holdings - Bathi saben saham sajroning taun lumaku|MAIA (MAIA Biotechnology) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) liminatuspharma.com|Bathi saben saham sajrone rolas wulan pungkasan LAVA Therapeutics N.V. (LVTX)|NXTC: Bathi saben siji saham sajrone 12 wulan pungkasan|Leap Therapeutics - Bathi resik saben saham sajrone 12 wulan pungkasan|Sensei Biotherapeutics Inc (SNSE) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Theriva Biologics, Inc. - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan Gritstone bio, Inc. GRTS|Kineta (KA) - Bathi saben saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone 12 wulan pungkasan NEXI|Bathi resik saben saham sajrone 12 wulan pungkasan TSBX|VCNX (Vaccinex Inc) - Bathi saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham (EPS TTM) HARP